Drug resistant hypertension and Munchausen syndrome.
- Published in:
- Arterial Hypertension, 2022, v. 26, n. 1, p. 39, doi. 10.5603/AH.a2022.0002
- By:
- Publication type:
- Article
Works matching IS 24496170 AND DT 2022 AND VI 26 AND IP 1
Results: 6
1
2
Effectiveness of a self-management education program on hypertension control and contributing factors in older adults: an interventional trial.
- Published in:
- Arterial Hypertension, 2022, v. 26, n. 1, p. 32, doi. 10.5603/AH.a2021.0025
- By:
- Publication type:
- Article
3
Leptin in obesity and hypertension.
- Published in:
- Arterial Hypertension, 2022, v. 26, n. 1, p. 26, doi. 10.5603/AH.a2022.0003
- By:
- Publication type:
- Article
4
Early detection of myocardial damage using 2D speckle tracking echocardiography through strain assessment in hypertensive patients.
- Published in:
- Arterial Hypertension, 2022, v. 26, n. 1, p. 15, doi. 10.5603/AH.a2022.0001
- By:
- Publication type:
- Article
5
COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.
- Published in:
- Arterial Hypertension, 2022, v. 26, n. 1, p. 9, doi. 10.5603/AH.a2022.0005
- By:
- Publication type:
- Article
6
Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2.
- Published in:
- Arterial Hypertension, 2022, v. 26, n. 1, p. 1, doi. 10.5603/AH.a2021.0014
- By:
- Publication type:
- Article